Defense Threat Reduction Agency

U.S. Combat Support Agency for countering WMD

Follow Defense Threat Reduction Agency on Notably News to receive short updates to your email — rarely!

February 2024	DTRA Director Rebecca Hersman announced the agency would transition its intelligence resources and authorities to the Defense Intelligence Agency in her Strategic Intent 2022-2027 document.
2022	Rebecca Hersman becomes Director of the Defense Threat Reduction Agency and continues in the role as of the current date.
2021	Dr. Rhys M. Williams serves as Acting Director of the agency.
2020	DOMANE began researching existing, pre-approved medications like Pepcid (famotidine) as potential cost-effective treatments for COVID-19 during the pandemic.
November 2019	The Defense Threat Reduction Agency established the Discovery of Medical Countermeasures Against Novel Entities (DOMANE) program to research potential medical treatments.
2017	Michael L. Bruhn serves as Acting Director before Vayl S. Oxford takes over.
2017	Responsibility for Combating WMD objectives was moved from USSTRATCOM to U.S. Special Operations Command (USSOCOM).
2016	Shari Durand serves as Acting Director of the agency.
September 30 2016	The Joint Improvised-Threat Defeat Agency (JIDA) became part of DTRA and was renamed the Joint Improvised-Threat Defeat Organization (JIDO) in accordance with the 2016 National Defense Authorization Act.
2012	The Standing Joint Force Headquarters for Elimination (SJFHQ-E) was relocated to the DTRA/SCC-WMD headquarters at Fort Belvoir, centralizing the DoD's Combating Weapons of Mass Destruction operations.

This contents of the box above is based on material from the Wikipedia article Defense Threat Reduction Agency, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.